Founded in 2021, Clone Robotics operates in robotics. Investors last valued the company at $30M. No public ticker exists for the company.
One company valuation: $30M.
Initialized CapitalLEADAAccess VCPPioneer FundWWikus VenturesTTango VCClone Robotics is a Polish technology company specializing in the development of bionic robots, with core products designed to simulate human musculoskeletal systems. The Clone's muscular system animates the skeleton thanks to Clone's revolutionary artificial muscle technology Myofiber, pioneered by Clone in 2021. Its origin product, the Clone Hand, is a hydraulic musculoskeletal hand with 27 degrees of freedom, developed over roughly eight years, originally under the name Automaton Robotics. Clone Robotics was founded in 2021 by Radhakrishnan and Polish engineer Lukasz Kozlik.
Clone is a bipedal android companion, made for individuals and businesses alike, built on the viral Protoclone V1 full-body prototype. Clone's own roadmap targets a surgical-grade torso in late 2026, a walking demo in 2027, and a first commercial Robo Butler product in 2028.
Listed funds carry late-stage private names. A fund's latest schedule of investments shows whether it holds Clone Robotics.
Often trade at a premium or discount to NAV.
Platforms match existing holders with buyers. Clone Robotics availability at any moment is set by the holders.
High minimums, transfer approval, company right-of-first-refusal.
Valuations, rounds and IPO status for every company in the directory — Clone Robotics included.
Lead investors for each round are in the funding timeline.
The closest robotics peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
No. Clone Robotics is a private company; its shares do not trade on a public exchange.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
